{"id":"https://openalex.org/W2521908707","doi":"https://doi.org/10.21115/jbes.v8.n2.p155-163","title":"An\u00e1lise de custo por resposta dos medicamentos biol\u00f3gicos no tratamento da psor\u00edase moderada a grave sob as perspectivas dos sistemas de sa\u00fade p\u00fablico e privado, no Brasil","display_name":"An\u00e1lise de custo por resposta dos medicamentos biol\u00f3gicos no tratamento da psor\u00edase moderada a grave sob as perspectivas dos sistemas de sa\u00fade p\u00fablico e privado, no Brasil","alternate_titles":["Cost per responder analysis of biologic drugs for the treatment of moderate to severe psoriasis under Brazilian public and private healthcare systems perspectives"],"publication_year":2016,"publication_date":"2016-08-20","ids":{"openalex":"https://openalex.org/W2521908707","doi":"https://doi.org/10.21115/jbes.v8.n2.p155-163","mag":"2521908707"},"language":"pt","primary_location":{"id":"doi:10.21115/jbes.v8.n2.p155-163","doi":"https://doi.org/10.21115/jbes.v8.n2.p155-163","is_oa":true,"landing_page_url":"https://doi.org/10.21115/jbes.v8.n2.p155-163","pdf_url":"https://doi.org/10.21115/jbes.v8.n2.p155-163","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jornal Brasileiro de Economia da Sa\u00fade","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2521908707"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.21115/jbes.v8.n2.p155-163","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038233953","display_name":"Luciana Scaccabarozzi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Luciana Scaccabarozzi","raw_affiliation_strings":["S\u00e3o Paulo , Brasil",". Gerente de Farmacoeconomia e Acesso, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S\u00e3o Paulo , Brasil","institution_ids":[]},{"raw_affiliation_string":". Gerente de Farmacoeconomia e Acesso, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5096374573","display_name":"Cintia Del Rey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cintia Rey","raw_affiliation_strings":[". Medical Science Liaison, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Medical Science Liaison, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088015638","display_name":"Hellen Kim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hellen Kim","raw_affiliation_strings":[". Analista de Projetos, Sense Company, S\u00e3o Paulo, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Analista de Projetos, Sense Company, S\u00e3o Paulo, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112215867","display_name":"Laura Amaral","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Laura Amaral","raw_affiliation_strings":[". Gerente de Projetos, Sense Company, Rio de Janeiro, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Gerente de Projetos, Sense Company, Rio de Janeiro, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049952733","display_name":"Roberta Ribeiro Fernandes","orcid":"https://orcid.org/0000-0002-1314-9352","observed_orcids":["https://orcid.org/0000-0002-1314-9352"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roberta Fernandes","raw_affiliation_strings":[". Diretora M\u00e9dica, Sense Company, Rio de Janeiro, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Diretora M\u00e9dica, Sense Company, Rio de Janeiro, Brasil","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001951839","display_name":"Elio Fernando Asano","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elio Asano","raw_affiliation_strings":[". Head de Farmacoeconomia e Acesso, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Head de Farmacoeconomia e Acesso, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5085028964","display_name":"Isabel Genov","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Isabel Genov","raw_affiliation_strings":[". Gerente M\u00e9dica, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":". Gerente M\u00e9dica, Janssen-Cilag Farmac\u00eautica Ltda., S\u00e3o Paulo, Brasil","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.5284,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.60211167,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":95},"biblio":{"volume":"8","issue":"2","first_page":"155","last_page":"163"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.8285999894142151,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.8285999894142151,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.15320000052452087,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cost-per-response","display_name":"cost per response","score":0.753000020980835},{"id":"https://openalex.org/keywords/psoriasis","display_name":"psoriasis","score":0.7879999876022339},{"id":"https://openalex.org/keywords/moderate-to-severe-psoriasis","display_name":"moderate-to-severe psoriasis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/biologic-drugs","display_name":"biologic drugs","score":0.7490000128746033},{"id":"https://openalex.org/keywords/ustekinumab","display_name":"ustekinumab","score":0.843999981880188},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.8880000114440918},{"id":"https://openalex.org/keywords/etanercept","display_name":"etanercept","score":0.9900000095367432},{"id":"https://openalex.org/keywords/infliximab","display_name":"infliximab","score":0.9860000014305115},{"id":"https://openalex.org/keywords/pasi-75","display_name":"PASI 75","score":0.8989999890327454},{"id":"https://openalex.org/keywords/health-technology-assessment","display_name":"health technology assessment","score":0.5569999814033508},{"id":"https://openalex.org/keywords/supplementary-health-system","display_name":"supplementary health system","score":0.578000009059906},{"id":"https://openalex.org/keywords/unified-health-system-sus","display_name":"Unified Health System (SUS)","score":0.9300000071525574},{"id":"https://openalex.org/keywords/dose-adjustment","display_name":"dose adjustment","score":0.5619999766349792},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.5680000185966492},{"id":"https://openalex.org/keywords/brazil","display_name":"Brazil","score":0.6110000014305115},{"id":"https://openalex.org/keywords/sao-paulo-state","display_name":"S\u00e3o Paulo state","score":0.7369999885559082},{"id":"https://openalex.org/keywords/health-decision-making","display_name":"health decision-making","score":0.5590000152587891},{"id":"https://openalex.org/keywords/sensitivity-analysis","display_name":"sensitivity analysis","score":0.546999990940094}],"concepts":[{"id":"https://openalex.org/C15708023","wikidata":"https://www.wikidata.org/wiki/Q80083","display_name":"Humanities","level":1,"score":0.4576387405395508},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44822484254837036},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.1686578392982483}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.21115/jbes.v8.n2.p155-163","doi":"https://doi.org/10.21115/jbes.v8.n2.p155-163","is_oa":true,"landing_page_url":"https://doi.org/10.21115/jbes.v8.n2.p155-163","pdf_url":"https://doi.org/10.21115/jbes.v8.n2.p155-163","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jornal Brasileiro de Economia da Sa\u00fade","raw_type":"journal-article"},{"id":"pmh:oai:ojs2.revista.jbes.com.br:article/323","doi":null,"is_oa":true,"landing_page_url":"https://www.jbes.com.br/index.php/jbes/article/view/323","pdf_url":"https://www.jbes.com.br/index.php/jbes/article/download/323/293","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"2175-2095","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.21115/jbes.v8.n2.p155-163","doi":"https://doi.org/10.21115/jbes.v8.n2.p155-163","is_oa":true,"landing_page_url":"https://doi.org/10.21115/jbes.v8.n2.p155-163","pdf_url":"https://doi.org/10.21115/jbes.v8.n2.p155-163","source":{"id":"https://openalex.org/S4210220290","display_name":"Jornal Brasileiro de Economia da Sa\u00fade","issn_l":"2175-2095","issn":["2175-2095","2359-1641"],"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Jornal Brasileiro de Economia da Sa\u00fade","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8560000061988831,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2521908707.pdf","grobid_xml":"https://content.openalex.org/works/W2521908707.grobid-xml"},"referenced_works_count":38,"referenced_works":["https://openalex.org/W1515251814","https://openalex.org/W1587177792","https://openalex.org/W1661616496","https://openalex.org/W1692288477","https://openalex.org/W1746441252","https://openalex.org/W1873491332","https://openalex.org/W1966302674","https://openalex.org/W1975162362","https://openalex.org/W1976208013","https://openalex.org/W1977350622","https://openalex.org/W1990882766","https://openalex.org/W2010272366","https://openalex.org/W2010277266","https://openalex.org/W2021018799","https://openalex.org/W2033988686","https://openalex.org/W2044368821","https://openalex.org/W2053582742","https://openalex.org/W2062156425","https://openalex.org/W2069350424","https://openalex.org/W2080165152","https://openalex.org/W2111247729","https://openalex.org/W2116956799","https://openalex.org/W2121588356","https://openalex.org/W2128340413","https://openalex.org/W2129777700","https://openalex.org/W2133633410","https://openalex.org/W2152262899","https://openalex.org/W2168384861","https://openalex.org/W2172257129","https://openalex.org/W2323925800","https://openalex.org/W2328871474","https://openalex.org/W2383137591","https://openalex.org/W2395451510","https://openalex.org/W2469096048","https://openalex.org/W4211077900","https://openalex.org/W4256202408","https://openalex.org/W6603036350","https://openalex.org/W6808308688"],"related_works":["https://openalex.org/W7216877676","https://openalex.org/W2936770744","https://openalex.org/W4280654366","https://openalex.org/W7216676999","https://openalex.org/W3117991710","https://openalex.org/W2115474873","https://openalex.org/W4388508736","https://openalex.org/W3025264433","https://openalex.org/W2033583087","https://openalex.org/W2810927735"],"abstract_inverted_index":{"Objetivo:":[0],"Estimar":[1],"o":[2,86,114,133,197,232,237],"custo":[3,80,135,170,239],"por":[4,136,142,147,171,179,240],"resposta":[5,69,137,172,241],"dos":[6,72,90],"medicamentos":[7,45,73],"biol\u00f3gicos":[8,46],"no":[9,41,166,216],"tratamento":[10,82],"da":[11,36,247],"psor\u00edase":[12],"moderada":[13],"a":[14,68,96,110,127],"grave":[15],"sob":[16,126],"as":[17,227],"perspectivas":[18],"do":[19,81,129,164],"Sistema":[20,26],"de":[21,28,34,38,58,62,77,88,101,106,112,144,175,191,203,214,218],"Sa\u00fade":[22,29,37],"Suplementar":[23],"(SSS)":[24],"e":[25,54,95,154,186],"\u00danico":[27],"(SUS),":[30],"representado":[31],"pela":[32],"Secretaria":[33],"Estado":[35],"S\u00e3o":[39],"Paulo,":[40],"Brasil.":[42],"M\u00e9todos:":[43],"Quatro":[44],"foram":[47,60],"considerados":[48],"na":[49,74,99,162,201],"an\u00e1lise:":[50],"adalimumabe,":[51],"etanercepte,":[52],"infliximabe":[53,148,180],"ustequinumabe.":[55],"Os":[56],"dados":[57],"efic\u00e1cia":[59],"obtidos":[61],"uma":[63],"metan\u00e1lise":[64],"publicada,":[65],"que":[66,235],"avaliou":[67],"PASI":[70,138,173,242],"75":[71,139,174,243],"semana":[75],"24":[76],"tratamento.":[78],"O":[79],"foi":[83,108,160],"obtido":[84],"considerando":[85],"pre\u00e7o":[87],"aquisi\u00e7\u00e3o":[89],"medicamentos,":[91],"conforme":[92],"perspectiva":[93,128,163,248],"analisa[1]da,":[94],"posologia":[97],"preconizada":[98],"bula":[100],"cada":[102],"um":[103],"deles.":[104],"An\u00e1lise":[105],"sensibilidade":[107],"conduzida":[109],"fim":[111],"avaliar":[113],"impacto":[115],"das":[116],"incertezas":[117],"nos":[118],"resultados":[119],"encontrados.":[120],"Resultados:":[121],"A":[122,221],"an\u00e1lise":[123,202,223],"mostrou":[124,195,224],"que,":[125,225],"SSS,":[130],"ustequinumabe":[131,168,194,230],"apresentou":[132,169],"menor":[134,238],"(R$":[140,149,152,156,181,184,188],"66.371)":[141],"ano":[143],"tratamento,":[145],"seguido":[146,178],"139.605),":[150],"adalimumabe":[151,183],"152.501)":[153],"etanercepte":[155,187],"179.812).":[157],"Resultado":[158],"semelhante":[159],"observado":[161],"SUS,":[165],"qual":[167],"R$":[176],"47.229,":[177],"75.145),":[182],"90.292)":[185],"130.523).":[189],"Ajuste":[190],"dose":[192],"para":[193,211],"ser":[196],"par\u00e2metro":[198],"mais":[199],"sens\u00edvel":[200],"sensibilidade.":[204],"Conclus\u00e3o:":[205],"Avalia\u00e7\u00f5es":[206],"econ\u00f4micas":[207],"s\u00e3o":[208],"ferramentas":[209],"importantes":[210],"auxiliar":[212],"gestores":[213],"sa\u00fade":[215],"processo":[217],"tomada":[219],"decis\u00e3o.":[220],"presente":[222],"dentre":[226],"alternativas":[228],"comparadas,":[229],"\u00e9":[231],"medicamento":[233],"biol\u00f3gico":[234],"apresenta":[236],"(mais":[244],"custo-efetivo),":[245],"independentemente":[246],"analisada":[249],"(p\u00fablico":[250],"ou":[251],"privado).":[252]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2521908707","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-09-30T00:00:00"}
